BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 21570089)

  • 1. Practical guidelines for managing patients with 22q11.2 deletion syndrome.
    Bassett AS; McDonald-McGinn DM; Devriendt K; Digilio MC; Goldenberg P; Habel A; Marino B; Oskarsdottir S; Philip N; Sullivan K; Swillen A; Vorstman J;
    J Pediatr; 2011 Aug; 159(2):332-9.e1. PubMed ID: 21570089
    [No Abstract]   [Full Text] [Related]  

  • 2. Practical guidelines for managing adults with 22q11.2 deletion syndrome.
    Fung WL; Butcher NJ; Costain G; Andrade DM; Boot E; Chow EW; Chung B; Cytrynbaum C; Faghfoury H; Fishman L; García-Miñaúr S; George S; Lang AE; Repetto G; Shugar A; Silversides C; Swillen A; van Amelsvoort T; McDonald-McGinn DM; Bassett AS
    Genet Med; 2015 Aug; 17(8):599-609. PubMed ID: 25569435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognizing a common genetic syndrome: 22q11.2 deletion syndrome.
    Kapadia RK; Bassett AS
    CMAJ; 2008 Feb; 178(4):391-3. PubMed ID: 18268261
    [No Abstract]   [Full Text] [Related]  

  • 4. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial Syndrome.
    Sullivan KE
    Immunol Allergy Clin North Am; 2008 May; 28(2):353-66. PubMed ID: 18424337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling for the 22q11.2 deletion.
    McDonald-McGinn DM; Zackai EH
    Dev Disabil Res Rev; 2008; 14(1):69-74. PubMed ID: 18636638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction: advances in research on velo-cardio-facial syndrome/22q11.2 deletion syndrome.
    Kates WR; Emanuel BS
    Dev Disabil Res Rev; 2008; 14(1):1-2. PubMed ID: 18636630
    [No Abstract]   [Full Text] [Related]  

  • 7. Malignancy in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
    McDonald-McGinn DM; Reilly A; Wallgren-Pettersson C; Hoyme HE; Yang SP; Adam MP; Zackai EH; Sullivan KE
    Am J Med Genet A; 2006 Apr; 140(8):906-9. PubMed ID: 16532473
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo-cardio-facial syndrome).
    Digilio MC; Giannotti A; Castro M; Colistro F; Ferretti F; Marino B; Dallapiccola B
    Am J Med Genet A; 2003 Sep; 121A(3):286-8. PubMed ID: 12923874
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes).
    Perez E; Sullivan KE
    Curr Opin Pediatr; 2002 Dec; 14(6):678-83. PubMed ID: 12436034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Counseling families with chromosome 22q11 deletions: the catch in CATCH-22.
    Bristow JD; Bernstein HS
    J Am Coll Cardiol; 1998 Aug; 32(2):499-501. PubMed ID: 9708482
    [No Abstract]   [Full Text] [Related]  

  • 11. The Philadelphia story: the 22q11.2 deletion: report on 250 patients.
    McDonald-McGinn DM; Kirschner R; Goldmuntz E; Sullivan K; Eicher P; Gerdes M; Moss E; Solot C; Wang P; Jacobs I; Handler S; Knightly C; Heher K; Wilson M; Ming JE; Grace K; Driscoll D; Pasquariello P; Randall P; Larossa D; Emanuel BS; Zackai EH
    Genet Couns; 1999; 10(1):11-24. PubMed ID: 10191425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility gene card for: DiGeorge syndrome, velocardiofacial syndrome, Shprintzen syndrome, chromosome 22q11.2 deletion syndrome (22q11.2, TBX1).
    Schwinger E; Devriendt K; Rauch A; Philip N
    Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20125192
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of 22q11.2 deletion syndrome in the context of newly developed psychosis].
    Kaltenboeck A; Friedrich F; Hinterbuchinger B; Litvan Z; Mossaheb N
    Neuropsychiatr; 2016 Dec; 30(4):223-226. PubMed ID: 27822729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DiGeorge syndrome/velocardiofacial syndrome: the chromosome 22q11.2 deletion syndrome.
    Sullivan KE
    Adv Exp Med Biol; 2007; 601():37-49. PubMed ID: 17712990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical presentations of 22q11.2 deletion syndrome: explaining the genetic defects and genome architecture.
    Tuţulan-Cuniţă AC; Budişteanu M; Papuc SM; Dupont JM; Blancho D; Lebbar A; Viot G; Lungeanu A; Arghir A
    Psychiatry Res; 2012 May; 197(3):356-7. PubMed ID: 22365273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [22q11.2 deletion syndrome].
    Ishikawa T
    Nihon Rinsho; 2006 Jun; Suppl 2():70-3. PubMed ID: 16817353
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic and clinical characteristics of 22q11.2 deletion syndrome].
    Kozlova IuO; Zabnenkova VV; Shilova NV; Min'zhenkova ME; Antonenko VG; Kotlukova NP; Simonova LV; Kazanceva IA; Levchenko EG; Bombardirova TD; Zolotukhina TV; Poliakov AV
    Genetika; 2014 May; 50(5):602-10. PubMed ID: 25715476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Microdeletion of 22q11, DiGeorge and velocardiofacial syndrome].
    Hjalgrim H; Hahnemann JM; Timshel S; Brøndum-Nielsen K
    Ugeskr Laeger; 2000 Jul; 162(31):4169-70. PubMed ID: 10962926
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune and Genetic Features of the Chromosome 22q11.2 Deletion (DiGeorge Syndrome).
    Kuo CY; Signer R; Saitta SC
    Curr Allergy Asthma Rep; 2018 Oct; 18(12):75. PubMed ID: 30377837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular basis of microdeletion 22q11].
    Bouvagnet P
    Arch Pediatr; 2002 May; 9 Suppl 2():97s-99s. PubMed ID: 12108307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.